# Oligomeric lactic acid nanoplastics induce intrauterine growth restriction in mice by disrupting GATA2-mediated placental vascular development

**Authors:** Jia Lv, Mengjing Wang, Changzhi Shi, Yanwei Wang, Yihao Zhang, Chang Gao, Tian-Qi Bi, Jing Yang, Youdong Xu, Qunan Wang, Hua Wang, De-Xiang Xu, Mingliang Fang, Yichao Huang

PMC · DOI: 10.1371/journal.pbio.3003676 · PLOS Biology · 2026-03-26

## TL;DR

This study shows that oligomeric lactic acid nanoplastics from biodegradable plastic can harm fetal development in mice by disrupting placental blood vessel growth.

## Contribution

The study reveals that OLA nanoplastics breach the placental barrier and impair fetal growth via GATA2-mediated vascular disruption.

## Key findings

- OLA nanoplastics accumulate in fetal organs and placenta in mice.
- Gestational OLA exposure causes placental vascular dysplasia and fetal growth restriction.
- OLA blocks the VEGF pathway and prevents GATA2 nuclear translocation.

## Abstract

Humans are increasingly exposed to "eco-friendly" biodegradable microplastic pollution, whose usage in packaging and medical applications is growing exponentially. The bioplastic polylactic acid (PLA) has recently been demonstrated to release large quantities of oligomeric lactic acid (OLA) nanoplastics causing adverse health effects. No research has reported on intrauterine biodistribution of OLA, and how gestational exposure may impact on early development of the fetus. Here, we reveal that OLA plastics can readily breach the placental barrier and accumulate in various fetal organs in a mouse model. Gestational exposure to environmentally relevant dose of OLA impairs vasculature development, causing intrauterine growth restriction in the pups. Mechanistically, OLA causes blockage of the vascular endothelial growth factor pathway and abnormal physiological development of placenta, which is mediated by the obstruction of transcription factor GATA2 translocation into the nucleus. This study highlights the potential developmental health effect of oligomer nanoparticles released from biodegradable PLA plastic.

Polylactic acid is a widely used biodegradable plastic, which can be broken down into oligomeric lactic acid (OLA) nanoplastics. This study shows that OLA particles can accumulate in the placenta and fetus of pregnant mice and induce placental vascular dysplasia and fetal growth restriction.

## Linked entities

- **Genes:** GATA2 (GATA binding protein 2) [NCBI Gene 2624]
- **Chemicals:** polylactic acid (PubChem CID 61503), lactic acid (PubChem CID 612)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Hprt1 (hypoxanthine phosphoribosyltransferase 1) [NCBI Gene 15452] {aka HPGRT, Hprt}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Vegfd (vascular endothelial growth factor D) [NCBI Gene 14205] {aka Figf, VEGF-D}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, CD34 (CD34 molecule) [NCBI Gene 947], Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Flt1 (FMS-like tyrosine kinase 1) [NCBI Gene 14254] {aka Flt-1, VEGFR-1, VEGFR1, sFlt1}, Kdr (kinase insert domain protein receptor) [NCBI Gene 16542] {aka 6130401C07, Flk-1, Flk1, Krd-1, Ly73, VEGFR-2}, GATA2 (GATA binding protein 2) [NCBI Gene 2624] {aka DCML, IMD21, MONOMAC, NFE1B}, KPNA6 (karyopherin subunit alpha 6) [NCBI Gene 23633] {aka IPOA7}, Gata2 (GATA binding protein 2) [NCBI Gene 14461] {aka Gata-2}, Rflnb (refilin B) [NCBI Gene 76566] {aka 1500005K14Rik, Fam101b, RefilinB, cfm}, KPNA5 (karyopherin subunit alpha 5) [NCBI Gene 3841] {aka IPOA6, SRP6}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, CD1B (CD1b molecule) [NCBI Gene 910] {aka CD1, R1}, SPR (sepiapterin reductase) [NCBI Gene 6697] {aka SDR38C1}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, Cdh5 (cadherin 5) [NCBI Gene 12562] {aka 7B4, Cd144, VE-Cad, VECD, VEcad, Vec}, LMNB1 (lamin B1) [NCBI Gene 4001] {aka ADLD, LMN, LMN2, LMNB, MCPH26}
- **Diseases:** chronic kidney disease (MESH:D051436), stillbirth (MESH:D050497), HPVEC (MESH:D014652), inflammation (MESH:D007249), cardiotoxicity (MESH:D066126), IUGR (MESH:D005317), ID (MESH:C537985), hypoxia (MESH:D000860), placental and fetal abnormalities (MESH:D005315), REML (MESH:D002313), coronary heart disease (MESH:D003327), DOHaD (OMIM:603663), diabetes (MESH:D003920), Placental vascular dysplasia (MESH:D010922), LMMs (MESH:D004195), toxicity (MESH:D064420), obesity (MESH:D009765), OLA (MESH:C565446)
- **Chemicals:** glycine-HCl (MESH:D005998), water (MESH:D014867), saline (MESH:D012965), nitrogen (MESH:D009584), formic acid (MESH:C030544), sodium acetate (MESH:D019346), amine (MESH:D000588), Tween-20 (MESH:D011136), corn oil (MESH:D003314), H&amp;E (MESH:D006371), penicillin (MESH:D010406), DMSO (MESH:D004121), PBS (MESH:D007854), ethyl acetate (MESH:C007650), ethanolamine (MESH:D019856), acetonitrile (MESH:C032159), ester (MESH:D004952), styrene (MESH:D020058), TRIzol (MESH:C411644), corn starch (MESH:D013213), SDS (MESH:D012967), DAPI (MESH:C007293), EDC (MESH:C024565), MPs (MESH:D000080545), FITC (MESH:D016650), CCK8 (MESH:D012844), Phalloidin (MESH:D010590), lactic acid (MESH:D019344), polystyrene (MESH:D011137), polycaprolactone (MESH:C016240), Carbon (MESH:D002244), oxygen (MESH:D010100), Lipofectamine 2000 (MESH:C086724), PLA (MESH:C033616), hydrogen (MESH:D006859), streptomycin (MESH:D013307), BS350A (-), Agarose (MESH:D012685), polybrene (MESH:D006583), polymer (MESH:D011108), plastics (MESH:D010969)
- **Species:** Daphnia magna (species) [taxon 35525], Homo sapiens (human, species) [taxon 9606], Ectocarpus siliculosus (species) [taxon 2880], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C) for 3, C0048S
- **Cell lines:** HPVEC — Homo sapiens (Human), Somatic stem cell (CVCL_WG60), HUVEC — Homo sapiens (Human), Finite cell line (CVCL_3722), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), 293 T — Homo sapiens (Human), Transformed cell line (CVCL_0063)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13020787/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13020787/full.md

## References

76 references — full list in the complete paper: https://tomesphere.com/paper/PMC13020787/full.md

---
Source: https://tomesphere.com/paper/PMC13020787